Betta Pharmaceuticals Statistics
Total Valuation
SHE:300558 has a market cap or net worth of CNY 20.83 billion. The enterprise value is 22.95 billion.
| Market Cap | 20.83B |
| Enterprise Value | 22.95B |
Important Dates
The last earnings date was Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jun 17, 2025 |
Share Statistics
SHE:300558 has 420.73 million shares outstanding. The number of shares has increased by 0.57% in one year.
| Current Share Class | 420.73M |
| Shares Outstanding | 420.73M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 2.59% |
| Owned by Institutions (%) | 19.63% |
| Float | 236.72M |
Valuation Ratios
The trailing PE ratio is 47.07 and the forward PE ratio is 26.48.
| PE Ratio | 47.07 |
| Forward PE | 26.48 |
| PS Ratio | 5.58 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 5.74 |
| P/FCF Ratio | 205.13 |
| P/OCF Ratio | 23.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.99, with an EV/FCF ratio of 225.99.
| EV / Earnings | 52.03 |
| EV / Sales | 6.15 |
| EV / EBITDA | 18.99 |
| EV / EBIT | 37.43 |
| EV / FCF | 225.99 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.37.
| Current Ratio | 0.99 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 25.22 |
| Interest Coverage | 8.46 |
Financial Efficiency
Return on equity (ROE) is 6.75% and return on invested capital (ROIC) is 5.14%.
| Return on Equity (ROE) | 6.75% |
| Return on Assets (ROA) | 3.87% |
| Return on Invested Capital (ROIC) | 5.14% |
| Return on Capital Employed (ROCE) | 6.81% |
| Weighted Average Cost of Capital (WACC) | 6.22% |
| Revenue Per Employee | 2.09M |
| Profits Per Employee | 247,147 |
| Employee Count | 1,961 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.40 |
Taxes
In the past 12 months, SHE:300558 has paid 151.77 million in taxes.
| Income Tax | 151.77M |
| Effective Tax Rate | 26.46% |
Stock Price Statistics
The stock price has decreased by -3.28% in the last 52 weeks. The beta is 0.45, so SHE:300558's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -3.28% |
| 50-Day Moving Average | 44.70 |
| 200-Day Moving Average | 54.53 |
| Relative Strength Index (RSI) | 66.48 |
| Average Volume (20 Days) | 10,929,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300558 had revenue of CNY 3.73 billion and earned 441.16 million in profits. Earnings per share was 1.05.
| Revenue | 3.73B |
| Gross Profit | 2.95B |
| Operating Income | 613.18M |
| Pretax Income | 573.68M |
| Net Income | 441.16M |
| EBITDA | 1.21B |
| EBIT | 613.18M |
| Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 510.23 million in cash and 2.56 billion in debt, with a net cash position of -2.05 billion or -4.87 per share.
| Cash & Cash Equivalents | 510.23M |
| Total Debt | 2.56B |
| Net Cash | -2.05B |
| Net Cash Per Share | -4.87 |
| Equity (Book Value) | 6.86B |
| Book Value Per Share | 16.15 |
| Working Capital | -15.94M |
Cash Flow
In the last 12 months, operating cash flow was 877.33 million and capital expenditures -775.77 million, giving a free cash flow of 101.57 million.
| Operating Cash Flow | 877.33M |
| Capital Expenditures | -775.77M |
| Depreciation & Amortization | 592.88M |
| Net Borrowing | 206.96M |
| Free Cash Flow | 101.57M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 78.98%, with operating and profit margins of 16.43% and 11.82%.
| Gross Margin | 78.98% |
| Operating Margin | 16.43% |
| Pretax Margin | 15.37% |
| Profit Margin | 11.82% |
| EBITDA Margin | 32.32% |
| EBIT Margin | 16.43% |
| FCF Margin | 2.72% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | 17.02% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 33.40% |
| Buyback Yield | -0.57% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 2.12% |
| FCF Yield | 0.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300558 has an Altman Z-Score of 4.61 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 6 |